Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,461,401
-
Share change
-
-1,877,768
-
Total reported value
-
$2,254,412,796
-
Put/Call ratio
-
83%
-
Price per share
-
$47.50
-
Number of holders
-
168
-
Value change
-
-$50,380,882
-
Number of buys
-
95
-
Number of sells
-
64
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q1 2019
As of 31 Mar 2019,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,461,401 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Foresite Capital Management III, LLC, Bank of New York Mellon Corp, Consonance Capital Management LP, Foresite Capital Management II, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and WADDELL & REED FINANCIAL INC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.